{"id":"https://openalex.org/W2186583383","doi":null,"title":"RESVERATROL attenuates kainic acid-induced epilepsy in male swiss albino mice.","display_name":"RESVERATROL attenuates kainic acid-induced epilepsy in male swiss albino mice.","publication_year":2014,"publication_date":"2014-01-01","ids":{"openalex":"https://openalex.org/W2186583383","mag":"2186583383"},"language":"en","primary_location":{"id":"mag:2186583383","doi":null,"is_oa":false,"landing_page_url":"http://www.bvmj.bu.edu.eg/issues/27-2/23.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5107913941","display_name":"Samy Ali Hussein","orcid":"https://orcid.org/0000-0003-0387-6019","observed_orcids":["https://orcid.org/0000-0003-0387-6019"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Samy Hussein","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010432669","display_name":"Afaf Desouky Abdel Magid","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Afaf Desouky Abdel Magid","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5021994255","display_name":"Omnia M. Abd-Elhamed","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Omnia M. Abd-Elhamed","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12229","display_name":"Pharmacological Effects and Toxicity Studies","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/resveratrol","display_name":"resveratrol","score":1.0},{"id":"https://openalex.org/keywords/kainic-acid-induced-epilepsy","display_name":"kainic acid-induced epilepsy","score":0.953000009059906},{"id":"https://openalex.org/keywords/epileptogenesis","display_name":"epileptogenesis","score":0.7829999923706055},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":0.9509999752044678},{"id":"https://openalex.org/keywords/antioxidant-enzymes","display_name":"antioxidant enzymes","score":0.7699999809265137},{"id":"https://openalex.org/keywords/sialic-acid","display_name":"sialic acid","score":0.8640000224113464},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.8519999980926514},{"id":"https://openalex.org/keywords/nitric-oxide","display_name":"nitric oxide","score":0.9340000152587891},{"id":"https://openalex.org/keywords/malondialdehyde","display_name":"malondialdehyde","score":0.9670000076293945},{"id":"https://openalex.org/keywords/caspase-3","display_name":"caspase-3","score":0.9980000257492065},{"id":"https://openalex.org/keywords/dna-fragmentation","display_name":"DNA fragmentation","score":0.9779999852180481},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.8140000104904175},{"id":"https://openalex.org/keywords/anticonvulsant-activity","display_name":"anticonvulsant activity","score":0.8180000185966492},{"id":"https://openalex.org/keywords/anti-inflammatory-activity","display_name":"anti-inflammatory activity","score":0.5979999899864197},{"id":"https://openalex.org/keywords/free-radical-scavenging-activity","display_name":"free radical scavenging","score":0.699999988079071},{"id":"https://openalex.org/keywords/swiss-albino-mice","display_name":"Swiss mice","score":0.7519999742507935}],"concepts":[{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.7391689419746399},{"id":"https://openalex.org/C2776108384","wikidata":"https://www.wikidata.org/wiki/Q390239","display_name":"Kainic acid","level":4,"score":0.6841486096382141},{"id":"https://openalex.org/C2778401633","wikidata":"https://www.wikidata.org/wiki/Q418661","display_name":"Malondialdehyde","level":3,"score":0.6748055815696716},{"id":"https://openalex.org/C2776151105","wikidata":"https://www.wikidata.org/wiki/Q898814","display_name":"Oxidative stress","level":2,"score":0.6042075753211975},{"id":"https://openalex.org/C2778760513","wikidata":"https://www.wikidata.org/wiki/Q24773045","display_name":"Glutathione peroxidase","level":4,"score":0.5624147653579712},{"id":"https://openalex.org/C538909803","wikidata":"https://www.wikidata.org/wiki/Q116907","display_name":"Glutathione","level":3,"score":0.5579476356506348},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5198115110397339},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5171698927879333},{"id":"https://openalex.org/C2775838275","wikidata":"https://www.wikidata.org/wiki/Q410776","display_name":"Superoxide dismutase","level":3,"score":0.4803151488304138},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4627751111984253},{"id":"https://openalex.org/C57236427","wikidata":"https://www.wikidata.org/wiki/Q5382987","display_name":"Epileptogenesis","level":3,"score":0.4576410949230194},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4131212532520294},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3818744421005249},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.16755136847496033},{"id":"https://openalex.org/C61174792","wikidata":"https://www.wikidata.org/wiki/Q420510","display_name":"Glutamate receptor","level":3,"score":0.10339435935020447},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2186583383","doi":null,"is_oa":false,"landing_page_url":"http://www.bvmj.bu.edu.eg/issues/27-2/23.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":56,"referenced_works":["https://openalex.org/W114870922","https://openalex.org/W1466900835","https://openalex.org/W1522823711","https://openalex.org/W1532525845","https://openalex.org/W1595395957","https://openalex.org/W1599342152","https://openalex.org/W1734477456","https://openalex.org/W1801496384","https://openalex.org/W1965659213","https://openalex.org/W1965968130","https://openalex.org/W1966738002","https://openalex.org/W1969109023","https://openalex.org/W1969789630","https://openalex.org/W1983505131","https://openalex.org/W1985268049","https://openalex.org/W1989708825","https://openalex.org/W1995224512","https://openalex.org/W1996201404","https://openalex.org/W1996588072","https://openalex.org/W1997580846","https://openalex.org/W1997901451","https://openalex.org/W2010863774","https://openalex.org/W2011222740","https://openalex.org/W2015801271","https://openalex.org/W2020029292","https://openalex.org/W2026785969","https://openalex.org/W2032321427","https://openalex.org/W2036240959","https://openalex.org/W2038017090","https://openalex.org/W2038804100","https://openalex.org/W2047953178","https://openalex.org/W2048399408","https://openalex.org/W2054271640","https://openalex.org/W2059223526","https://openalex.org/W2060522591","https://openalex.org/W2064689926","https://openalex.org/W2064947977","https://openalex.org/W2068078405","https://openalex.org/W2069132215","https://openalex.org/W2076010718","https://openalex.org/W2077208139","https://openalex.org/W2085087221","https://openalex.org/W2086703549","https://openalex.org/W2089977716","https://openalex.org/W2090804892","https://openalex.org/W2093078425","https://openalex.org/W2094039864","https://openalex.org/W2098461884","https://openalex.org/W2105513604","https://openalex.org/W2113713934","https://openalex.org/W2139191974","https://openalex.org/W2144419601","https://openalex.org/W2154696007","https://openalex.org/W2160239222","https://openalex.org/W2167437143","https://openalex.org/W2487003599"],"related_works":["https://openalex.org/W1997580846","https://openalex.org/W1553012405","https://openalex.org/W2007591527","https://openalex.org/W2584414208","https://openalex.org/W4408978005","https://openalex.org/W2413582181","https://openalex.org/W3134864868","https://openalex.org/W1540850915","https://openalex.org/W7221339066","https://openalex.org/W2049911411"],"abstract_inverted_index":{"Epilepsy":[0],"is":[1,11],"a":[2,14,67],"highly":[3],"prevalent":[4],"serious":[5],"brain":[6,126,155,193,206,234,252,283,302],"disorder,":[7],"and":[8,30,125,134,150,162,175,192,199,205,213,233,240,249,266,274,291,296],"oxidative":[9],"stress":[10],"regarded":[12],"as":[13,112],"possible":[15],"mechanism":[16],"involved":[17],"in":[18,41,113,184,189,242,251,264,301],"epileptogenesis.":[19],"The":[20,177],"present":[21],"study":[22],"was":[23,110,221],"designed":[24],"to":[25,223,244],"evaluate":[26],"the":[27,138,272],"potential":[28,269],"protective":[29],"beneficial":[31],"effect":[32],"of":[33,70,140,145,219,231,276,282],"resveratrol":[34,258],"(RESV)":[35],"on":[36],"kainic":[37],"acid":[38,148],"(KA)-induced":[39],"epilepsy":[40,183,225,284],"mice.":[42],"Twenty":[43],"four":[44,52],"male":[45],"Swiss":[46],"Albino":[47],"mice":[48,57,64,81,98,185,265],"were":[49,129,215],"divided":[50],"into":[51],"groups.":[53],"Group":[54,61,77,93],"\u0399:(Control":[55],"group)":[56,80],"received":[58,82],"no":[59],"drugs.":[60],"\u03a0:(epilepsy-induced":[62],"group):":[63,97],"administered":[65,111],"with":[66,101],"single":[68],"dose":[69],"KA":[71,91,141,228],"(10":[72,84],"mg/kg":[73,85,103],"b.wt)":[74],"intraperitoneally":[75],"(i.p).":[76],"III:(epilepsy+RESV":[78],"protected":[79],"RESV":[83,109,220],"b.wt/day/i.p.)":[86],"for":[87,116,122,143,271],"7":[88],"days":[89,136],"before":[90],"administration.":[92],"IV:":[94],"(epilepsy+RESV":[95],"treated":[96],"first":[99],"injected":[100],"KA(10":[102],"b.wt/i.p.)":[104],"then":[105],"after":[106,131],"15":[107],"min.":[108],"group":[114],"III":[115],"3":[117,135],"consecutive":[118],"days.":[119],"Blood":[120],"samples":[121],"serum":[123,146,190,203],"separation":[124],"tissue":[127,156,194,207,235],"specimens":[128],"collected":[130],"12":[132],"hours":[133],"from":[137],"onset":[139],"administration":[142,259],"determination":[144],"sialic":[147],"(SA)":[149],"tumor":[151],"necrosis":[152],"factor":[153],"alpha(TNF-\u03b1),":[154],"superoxide":[157],"dismutase":[158],"(SOD),":[159],"catalase":[160],"(CAT)":[161],"glutathione":[163,167],"peroxidase":[164],"(GPx),":[165],"reduced":[166],"(GSH),":[168],"L-Malondialdehyde":[169],"(LMDA),":[170],"nitric":[171],"oxide":[172],"(NO),":[173],"caspase-3":[174,248,295],"DNA-fragmentation.":[176],"obtained":[178],"results":[179,255],"showed":[180],"that,":[181,257],"KAinduced":[182],"caused":[186],"significant":[187],"decrease":[188],"SA":[191,232],"SOD,":[195,236],"CAT,":[196,237],"GPX":[197,238],"activities":[198,239],"GSH":[200,241],"concentration.":[201],"However,":[202],"TNF-\u03b1":[204],"NO,":[208,246],"L-MDA":[209],"level,":[210],"caspase3":[211],"activity":[212],"DNA-fragmentation":[214,250],"significantly":[216],"increased.":[217],"Administration":[218],"able":[222],"mitigate":[224],"induced":[226],"by":[227,285],"through":[229],"increasing":[230],"addition":[243],"declining":[245],"L-MDA,":[247],"tissue.":[253],"These":[254],"suggest":[256],"attenuate":[260],"kainate-induced":[261],"epileptic":[262],"seizures":[263],"may":[267],"be":[268],"effectiveness":[270],"prevention":[273],"control":[275],"seizure":[277],"development,":[278],"has":[279],"anticonvulsant":[280],"therapies":[281],"its":[286],"anti-inflammatory":[287],"effect,":[288],"radical":[289],"scavenging":[290],"anti-apoptotic":[292],"activity,":[293],"inhibited":[294],"regenerating":[297],"endogenous":[298],"antioxidant":[299],"mechanisms":[300],"tissues.":[303]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}